According to the new market research report " HLA
Typing for Transplant Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s
Sequencing), Products & Services (Instruments, Reagents, Software),
Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic
Center) - Forecast to 2021", published by MarketsandMarkets™,The global
HLA typing for transplant market is projected to reach USD 753.9 Million by
2021 from USD 535.0 Million in 2016, at a CAGR of 7.1% from 2016 to 2021.
Browse and in-depth
TOC on "Transplant Diagnostics Market"
60 - Figures
203 - Pages
Market growth can be
attributed to factors such as the rising number of solid organ, soft tissue,
and stem cell transplantations; technological advancements in the field of organ
transplantation; increased funding, research grants, and public-private
investments; technological shift from serological assays to gene-based HLA
profiling; and improving healthcare infrastructure across developing countries.
Scope of the Report
This research report categorizes the HLA typing for
transplant market into the following segments and sub segments:
HLA Typing for
Transplant Market, By Technology
·
Non-Molecular
Assay
§
Serological Assay
§
Mixed Lymphocyte Culture Assay (MLC Assay)
·
Molecular
Assay
§
PCR-based
o
Sequence specific primer-PCR (SSP-PCR)
o
Sequence specific oligonucleotide-PCR (SSO-PCR)
·
Sequencing-based
§
Next Generation Sequencing
§
Sanger’s Sequencing
Please click here to
get the global report of Transplant
Diagnostics Market by Technology (PCR, SSO-PCR, SSP-PCR, NGS, Sanger’s
Sequencing, Microarray), Products & Services (Instruments, Reagents),
Application (Blood Profiling, Infectious Disease Testing), End User (Hospitals)
- Global forecast 2021
The global HLA typing for transplant market is projected to
reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, growing at a
CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such
as the rising number of solid organ, soft tissue, and stem cell
transplantations; technological advancements in the field of organ
transplantations; and increased funding, research grants, and public-private
investments. However, the high device costs associated with NGS and PCR-based
devices and limited medical reimbursements for organ donation and
transplantation procedures restrain the optimal growth of the HLA typing for
transplant market.